Correlation Between ProQR Therapeutics and Sellas Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ProQR Therapeutics and Sellas Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ProQR Therapeutics and Sellas Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ProQR Therapeutics BV and Sellas Life Sciences, you can compare the effects of market volatilities on ProQR Therapeutics and Sellas Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ProQR Therapeutics with a short position of Sellas Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of ProQR Therapeutics and Sellas Life.

Diversification Opportunities for ProQR Therapeutics and Sellas Life

-0.14
  Correlation Coefficient

Good diversification

The 3 months correlation between ProQR and Sellas is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding ProQR Therapeutics BV and Sellas Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sellas Life Sciences and ProQR Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ProQR Therapeutics BV are associated (or correlated) with Sellas Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sellas Life Sciences has no effect on the direction of ProQR Therapeutics i.e., ProQR Therapeutics and Sellas Life go up and down completely randomly.

Pair Corralation between ProQR Therapeutics and Sellas Life

Given the investment horizon of 90 days ProQR Therapeutics BV is expected to generate 0.61 times more return on investment than Sellas Life. However, ProQR Therapeutics BV is 1.64 times less risky than Sellas Life. It trades about 0.15 of its potential returns per unit of risk. Sellas Life Sciences is currently generating about -0.1 per unit of risk. If you would invest  211.00  in ProQR Therapeutics BV on November 27, 2024 and sell it today you would earn a total of  28.00  from holding ProQR Therapeutics BV or generate 13.27% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

ProQR Therapeutics BV  vs.  Sellas Life Sciences

 Performance 
       Timeline  
ProQR Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days ProQR Therapeutics BV has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in March 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Sellas Life Sciences 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Sellas Life Sciences are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak essential indicators, Sellas Life unveiled solid returns over the last few months and may actually be approaching a breakup point.

ProQR Therapeutics and Sellas Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ProQR Therapeutics and Sellas Life

The main advantage of trading using opposite ProQR Therapeutics and Sellas Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ProQR Therapeutics position performs unexpectedly, Sellas Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sellas Life will offset losses from the drop in Sellas Life's long position.
The idea behind ProQR Therapeutics BV and Sellas Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Share Portfolio
Track or share privately all of your investments from the convenience of any device